Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04889274Phase 1Completed
Phase 1, randomised, double-blind trial (4 arms), sponsored by Queen Mary University of London. Primary endpoints: Flow Mediated Dilatation at 28 days and Plasma Nitrite Concentration at 28 days. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04889274.